Form 4: Therapeutic Solutions International CEO Timothy Dixon Reports Significant Share Transactions
SEC Form 4 Filing
CEO Timothy Dixon reports acquiring and disposing of shares in Therapeutic Solutions International, Inc.
Summary
- On September 30, 2024, Timothy Dixon acquired 55,555,555 shares of Therapeutic Solutions International, Inc. at a price of $0.0009 per share.
- Also on September 30, 2024, Timothy Dixon disposed of an unspecified amount of common stock.
- Following these transactions, Dixon beneficially owns 563,239,133 shares of the company's common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a report of transactions, not an announcement of performance or strategy.
Industry Context
Form 4 filings are standard practice for reporting insider transactions, providing transparency to the market regarding the buying and selling activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of common stock acquisition and disposition. |
| 10/01/2024 | Date of earliest transaction. |
| 10/02/2024 | Date of signature on the report. |
Keywords
Therapeutic Solutions International, TSOI, Timothy Dixon, Form 4, Beneficial Ownership, Share Transactions, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.